On March 7, 2025, and again on March 10, scientists, healthcare workers, and more rallied in protest to Trump administration ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close contact with someone who is infected vulnerable to developing COVID ...

But what if you could avoid getting COVID-19 altogether? That’s the potential promise of a new study on a drug made by ...

An open letter to US Secretary of State Marco Rubio signed by hundreds of high-profile HIV doctors, researchers and public ...

Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, ...